EUSTRALIS PHARMACEUTICALS LIMITED (TRADING AS PRESSURA NEURO)
发明人:
Robert VINK
申请号：
MX2015017881
公开号：
MX2015017881A
申请日:
2014.07.02
申请国别(地区):
MX
年份:
2016
代理人:
摘要：
The present invention relates to a method of preventing and/or treating chronic traumatic encephalopathy by administering to a subject N-(3,5-Bis-trifluoromethyl-benzyl)-N-methyl-6-(piperazin-1-yl)- 4-o-tolyl nicotinamide or 4-alkyl-piperazin-1-yl derivatives thereof.La presente invención se refiere a un método para la prevención y/o tratamiento con la encefalopatía traumática crónica al administrarle a un sujeto N-(3,5-Bis-trifluorometil-bencil)-N-meti l-6-(piperazin-1-il)-4-o-tolil nicotinamida o sus derivados de 4-alquil-piperazin-1-ilo.
